MedTrace Logo

Clinical Validation of the Withings ECG Monitor for the Detection of Atrial Fibrillation

NCT05266235 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 274

Last updated 2023-03-28

No results posted yet for this study

Summary

The aim of the study is to demonstrate the performance of Withings WBS08 in the automatic identification of atrial fibrillation and sinus rhythm.

Conditions

Interventions

DEVICE

Validation of the Withings bodyscan scale WBS08

Participants will undergo simultaneous recordings of ECGs with the comparator and the study device

Sponsors & Collaborators

  • Withings

    lead INDUSTRY

Principal Investigators

  • Nicolas Lellouche, MD · Henri Mondor University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-14
Primary Completion
2022-07-28
Completion
2022-07-28

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05266235 on ClinicalTrials.gov